PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+7.6%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$442M
AUM Growth
+$442M
(+12%)
Cap. Flow
+$48M
Cap. Flow
% of AUM
10.87%
Top 10 Holdings %
Top 10 Hldgs %
37.89%
Holding
92
New
17
Increased
38
Reduced
28
Closed
8
Top Buys
| 1 |
UnitedHealth
UNH
|
$19M |
| 2 |
CVS Health
CVS
|
$13.8M |
| 3 |
HCA Healthcare
HCA
|
$13M |
| 4 |
Danaher
DHR
|
$4.45M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$4.13M |
Top Sells
| 1 |
Humana
HUM
|
$7.39M |
| 2 |
DexCom
DXCM
|
$6.74M |
| 3 |
Arcus Biosciences
RCUS
|
$4.84M |
| 4 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$4.67M |
| 5 |
Insulet
PODD
|
$4.61M |
Sector Composition
| 1 | Healthcare | 98.05% |
| 2 | Industrials | 1.73% |
| 3 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
ANI Pharmaceuticals
ANIP
$2.03B
| $6.32M | 1.4% |
137,226
+51,880
| +61% | +$2.39M |
|
27
Gossamer Bio
GOSS
$562M
| $6.18M | 1.36% |
546,421
-240,449
| -31% | -$2.72M |
|
|
28
BioCryst Pharmaceuticals
BCRX
$1.74B
| $5.54M | 1.22% |
400,001
+298,040
| +292% | +$4.13M |
|
|
29
Arcus Biosciences
RCUS
$1.13B
| $4.74M | 1.05% |
117,099
-119,538
| -51% | -$4.84M |
|
|
30
Insulet
PODD
$23.9B
| $4.52M | 1% |
17,000
-17,340
| -50% | -$4.61M |
|
31
Fulcrum Therapeutics
FULC
$351M
| $4.42M | 0.98% |
250,106
-88,690
| -26% | -$1.57M |
|
32
Maravai LifeSciences
MRVI
$350M
| $4.14M | 0.91% |
98,688
+8,688
| +10% | +$364K |
|
33
Dentsply Sirona
XRAY
$2.85B
| $4.1M | 0.91% |
73,566
-6,889
| -9% | -$384K |
|
34
Keros Therapeutics
KROS
$618M
| $4.09M | 0.9% |
+69,861
| New | +$4.09M |
|
|
BCYC
35
Bicycle Therapeutics
BCYC
$511M
| $3.94M | 0.87% |
64,800
-4,749
| -7% | -$289K |
|
36
Harvard Bioscience
HBIO
$22M
| $3.79M | 0.84% |
537,081
+61,714
| +13% | +$435K |
|
37
Azenta
AZTA
$1.4B
| $3.77M | 0.83% |
36,554
-3,446
| -9% | -$355K |
|
38
Sutro Biopharma
STRO
$72.7M
| $3.29M | 0.73% |
221,219
+57,830
| +35% | +$861K |
|
39
Tenet Healthcare
THC
$16.3B
| $3.27M | 0.72% |
+40,000
| New | +$3.27M |
|
40
Supernus Pharmaceuticals
SUPN
$2.53B
| $3.05M | 0.67% |
104,714
+4,299
| +4% | +$125K |
|
41
Kodiak Sciences
KOD
$478M
| $2.98M | 0.66% |
35,174
-1,528
| -4% | -$130K |
|
42
Repligen
RGEN
$6.88B
| $2.74M | 0.6% |
10,331
-9,669
| -48% | -$2.56M |
|
43
Alphatec Holdings
ATEC
$2.35B
| $2.69M | 0.59% |
234,923
-15,077
| -6% | -$172K |
|
|
IMGO
44
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $2.61M | 0.58% |
+110,000
| New | +$2.61M |
|
45
Veracyte
VCYT
$2.39B
| $2.57M | 0.57% |
62,264
+17,264
| +38% | +$711K |
|
46
Stereotaxis
STXS
$261M
| $2.56M | 0.57% |
413,218
-36,782
| -8% | -$228K |
|
47
Nurix Therapeutics
NRIX
$714M
| $2.54M | 0.56% |
+87,824
| New | +$2.54M |
|
48
Ionis Pharmaceuticals
IONS
$6.79B
| $2.44M | 0.54% |
80,238
-56,142
| -41% | -$1.71M |
|
49
Madrigal Pharmaceuticals
MDGL
$9.76B
| $2.43M | 0.54% |
28,670
-2,723
| -9% | -$231K |
|
50
AngioDynamics
ANGO
$417M
| $2.43M | 0.54% |
+87,969
| New | +$2.43M |
|